We found that the genetic alteration of HTR1D, HTR3A, HTR3B, and HTR6 was significantly associated with shorter OS in breast cancer patients (Figure 5C), whereas the genetic alteration of other HTRs were not found to be significantly associated with OS (Supplementary Figure 2). This evidence concerns the gene HTR6 and breast carcinoma.